Published July 1996
| Version v1
Journal article
Hyperfractionated external irradiation therapy in stage IIIB carcinoma of the uterine cervix - a prospective pilot study
Creators
- 1. Hospital Dr. Mario Gatti, SP (Brazil). Servico de Radioterapia
- 2. Pontificia Univ., Catolica de Campinas, SP (Brazil)
- 3. Hospital A.C. Camargo, Sao Paulo, SP (Brazil). Dept. de Radioterapia
Description
There is little information in literature about HFX in carcinoma of the cervix (only two published articles in 1995). This is the study that gave the highest total dose external HFX of 60x1.2=72 Gy in the pelvis. Theoretically through the linear formula this schedule of HFX would be equivalent to STD 30x2 Gy = 60 Gy, both treatments given in 30 working days. These HFX schedules must be tested to establish is safety. Results suggests that tolerance, late effects and survival with HFX used were similar to STD irradiation until now. It seems to be possible to further increase the total dose in the pelvis with HFX. (author)
Additional details
Additional titles
- Original title (Portuguese)
- Hiperfracionamento em carcinoma epidermoide do colo de utero, estadio IIIB - um estudo prospectivo
Publishing Information
- Journal Title
- Radiologia Brasileira
- Journal Volume
- 29
- Journal Issue
- 4
- Journal Page Range
- p. 181-188
- ISSN
- 0100-3984
- CODEN
- RDBRAS
INIS
- Country of Publication
- Brazil
- Country of Input or Organization
- Brazil
- INIS RN
- 29062985
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; DELAYED RADIATION EFFECTS; DOSE RATES; DOSE-RESPONSE RELATIONSHIPS; FRACTIONATED IRRADIATION; PATIENTS; RADIATION DOSES; SURVIVAL CURVES; SURVIVAL TIME; UROGENITAL SYSTEM DISEASES; UTERUS
- Descriptors DEC
- ANIMALS; BIOLOGICAL EFFECTS; BIOLOGICAL RADIATION EFFECTS; BODY; DISEASES; FEMALE GENITALS; IRRADIATION; MAMMALS; MAN; NEOPLASMS; ORGANS; PRIMATES; RADIATION EFFECTS; VERTEBRATES
Optional Information
- Notes
- 26 refs., 2 figs., 3 tabs.